Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukemia, Myelocytic, Acute
|
6892 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.740 | 1.000 | 10 | 2009 | 2016 | ||||||
Neoplasms
|
1644 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.060 | 1.000 | 6 | 2009 | 2019 | ||||||
Astrocytoma
|
59 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.720 | 1.000 | 4 | 2009 | 2014 | ||||||
Glioblastoma
|
281 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 2 | 2011 | 2016 | ||||||
Glioblastoma Multiforme
|
186 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2009 | 2011 | ||||||
Glioma
|
353 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.720 | 1.000 | 2 | 2011 | 2012 | ||||||
Hemangioma
|
24 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||||
Li-Fraumeni Syndrome
|
206 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2009 | 2018 | ||||||
Liver carcinoma
|
942 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 2 | 2016 | 2017 | ||||||
Malignant Neoplasms
|
1641 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||
melanoma
|
515 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.020 | 1.000 | 2 | 2010 | 2018 | ||||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.710 | 1.000 | 2 | 2012 | 2016 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of prostate
|
108 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenoid Cystic Carcinoma
|
30 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adult Fibrosarcoma
|
9 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Adult Glioblastoma
|
98 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, NONDELETION TYPE, X-LINKED
|
32 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Brain Neoplasms
|
204 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Brain Stem Glioma
|
45 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Central Nervous System Neoplasms
|
72 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Childhood Astrocytoma
|
39 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Childhood Glioblastoma
|
98 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Childhood Osteosarcoma
|
151 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Chondrosarcoma
|
8 | 0.605 | 0.520 | 2 | 208248389 | missense variant | G/A;C;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 |